Home/Filings/4/0001209191-23-037326
4//SEC Filing

Williams Timothy 4

Accession 0001209191-23-037326

CIK 0001347178other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:20 PM ET

Size

5.1 KB

Accession

0001209191-23-037326

Insider Transaction Report

Form 4
Period: 2023-06-13
Williams Timothy
SVP & General Counsel
Transactions
  • Sale

    Common Stock

    2023-06-13$6.56/sh14,600$95,75488,913 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.51 to $6.5986, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001748392

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:20 PM ET
Size
5.1 KB